Home › Funds › Deep Track Capital, LP › ACRS
Deep Track Capital, LP position in ACRS
ACLARIS THERAPEUTICS INC · Health Care
Deep Track Capital, LP reported holding 9,345,000 shares of ACRS (ACLARIS THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$49.4M, representing 0.74% of its reported portfolio and ranking #39 among its reported holdings. Deep Track Capital, LP has disclosed ACRS holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Deep Track Capital, LP's ACRS position evolved
Deep Track Capital, LP first disclosed a stake in ACRS in Q1 2026 at 9,345,000 shares (US$35.0M). The position peaked in Q2 2026 at 9,345,000 shares, worth US$49.4M. Across 2 filings, Deep Track Capital, LP held the position steady without any share-count change. The most recent filing (Q2 2026) shows 9,345,000 shares valued at US$49.4M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 9.35M | $35.04M | New |
| Q2 2026 | 9.35M | $49.44M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ACRS and 13F data
ACRS (ACLARIS THERAPEUTICS INC) is a Health Care company. 43 other funds we track also report a position in ACRS — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$67.3M), BML Capital Management, LLC (US$63.3M), Vivo Capital, LLC (US$35.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ACRS
- RA CAPITAL MANAGEMENT, L.P. 12.72M sh · $67.30M · Q2 2026
- BML Capital Management, LLC 11.97M sh · $63.35M · Q2 2026
- Vivo Capital, LLC 6.69M sh · $35.41M · Q2 2026
- Frazier Life Sciences Management, L.P. 4.93M sh · $26.06M · Q2 2026
- Rock Springs Capital Management LP 4.33M sh · $22.91M · Q2 2026
- Decheng Capital LLC 4.04M sh · $21.38M · Q2 2026
- SILVERARC CAPITAL MANAGEMENT, LLC 1.95M sh · $10.30M · Q2 2026
- Kalehua Capital Management LLC 1.83M sh · $9.69M · Q2 2026
- Jones Hill Capital LP 1.76M sh · $9.31M · Q2 2026
- Palo Alto Investors LP 1.61M sh · $8.54M · Q2 2026
- MPM BioImpact LLC 1.04M sh · $5.51M · Q2 2026
- Aldebaran Capital, LLC 936.73K sh · $4.96M · Q2 2026
More on Deep Track Capital, LP
FAQ
How long has Deep Track Capital, LP held ACRS?
Deep Track Capital, LP has disclosed ACRS holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
What is Deep Track Capital, LP's current position in ACRS?
As of Q2 2026, Deep Track Capital, LP holds 9.35M shares of ACRS (ACLARIS THERAPEUTICS INC), valued at $49.44M, representing 0.74% of its reported portfolio and ranking #39.
Has Deep Track Capital, LP been buying or selling ACRS?
In the latest 13F filing (Q2 2026), Deep Track Capital, LP held unchanged its position in ACRS. The position peaked in Q2 2026 at 9.35M shares.
Which other funds hold ACRS?
Other major institutional holders of ACRS include RA CAPITAL MANAGEMENT, L.P., BML Capital Management, LLC, Vivo Capital, LLC, among 43 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.